• Suche
1 Aktie gratis
Trading
Suche
1 Aktie gratis
Wertpapierhandel für 0 Euro
Trading
zero-Trading
ETF-Sparplan

Adherex Technologies Aktie

5,35EUR
+0,30EUR
+5,94%
26.05.2022
STU
5,79USD
+0,16USD
+2,84%
26.05.2022
NDB

WKN: A12A5F / ISIN: CA31447P1009 / Symbol: FENC

  Kaufen  
Verkaufen
oder
mehr Daten anzeigen
Werbung

Times and Sales (XETRA)

ZeitKursUmsatz
Zur Zeit stehen keine Daten zur Verfügung
weiter
Werbung

News zu Adherex Technologies Inc

13.05.22Adherex Technologies legte Quartalsergebnis vor
08.04.22FENC SHAREHOLDER ALERT: Jakubowitz Law Reminds Fennec Shareholders of a Lead Plaintiff Deadline of April 11, 2022
04.04.22SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fennec Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - FENC
01.04.22FENC SHAREHOLDER ALERT: Jakubowitz Law Reminds Fennec Shareholders of a Lead Plaintiff Deadline of April 11, 2022
29.03.22ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action - FENC
26.03.22SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fennec Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - FENC
24.03.22FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
17.03.22SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fennec Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - FENC

Analysen zu Adherex Technologies Inc

12.03.18Adherex Technologies Outperform
20.02.18Adherex Technologies Buy
29.11.17Adherex Technologies Buy

Aktuelle News zu

26.05.22Allied Electronics & Automation Offers More Than 1,500 Ready-to-Ship Electrical Connectivity Solutions
26.05.22dentalcorp Announces Annual General Meeting Voting Results
26.05.22dentalcorp Announces Annual General Meeting Voting Results
26.05.22CAVU HCM Launches Two New Free Integrations to Deliver Greater Value to Clients
26.05.22Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors
26.05.22CORNERSTONE BUILDING INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cornerstone Building Brands, ...
26.05.22Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Expansive, Diverse and Compelling New Cancer Research at the 2022 ASCO Annual Meeting
26.05.22The Wendy's Company Reaffirms 2022 Outlook
26.05.22Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors
26.05.22Selenskyj beklagt Zögerlichkeit bei Sanktionen gegen Russland
26.05.22Italian court dismisses case against Tenaris’s Chairman and Chief Executive Officer and two other Board members over allegedly improper payments
26.05.22Carbon Market: Results of May 18th Auction held between Québec and California
26.05.22Cantargia presents clinical interim results at ASCO 2022 highlighting the potential of nadunolimab in combination with checkpoint inhibitor
26.05.22Restaurant Brands International Inc. to Participate in RBC Capital Markets 2022 Global Consumer & Retail Conference
26.05.22Restaurant Brands International Inc. to Participate in RBC Capital Markets 2022 Global Consumer & Retail Conference
26.05.22DXC Technology, Lloyd's und IUA verlängern Vertrag zur Unterstützung der Transformation des Londoner Versicherungsmarktes
26.05.22Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing
26.05.22Rutschen die US-Börsen in einen langanhaltenden Bärenmarkt?
26.05.22Summit Midstream Partners, LP Announces Adjournment of Annual Meeting and Information for Reconvened Annual Meeting
26.05.22100% AND MLB ALL-STAR FERNANDO TATIS, JR. DEBUT 2022 LIMITED-EDITION SPORT PERFORMANCE EYEWEAR COLLECTION
26.05.22New 'rebel' elopement planner kicks tradition to the curb with all-inclusive service for alternative couples
26.05.22USA weisen Russlands Forderung nach Aufhebung von Sanktionen zurück
26.05.22Carisma Therapeutics to Present Latest Data from Phase 1 Clinical Trial of Engineered Macrophage Therapy at 2022 ASCO Annual Meeting
26.05.22BGL Announces the Sale of ROCA ACERO S.A. de C.V.
26.05.22Douglas Emmett Declares Quarterly Cash Dividend
26.05.22Venzee Technologies Updates Schedule Details for Webcast and First Quarter 2022 Financial Release
26.05.22Caris Life Sciences to Showcase Extensive Research with Leading Cancer Centers Reflecting Its Commitment to Improving Outcomes for Patients at ASCO 2022
26.05.22Venzee Technologies Updates Schedule Details for Webcast and First Quarter 2022 Financial Release
26.05.22NASDAQ, S&P 500 & Co: Tesla-Aktie, Apple-Aktie, Amazon-Aktie, Microsoft-Aktie & Co im Fokus: Das sind die Bilanzen der Tech-Riesen in der aktuellen Saison
26.05.22Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022
26.05.22Für Tesla: Musk sucht auf Twitter nach neuer Rechtsabteilung - und erntet Kritik
26.05.22Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting
26.05.22NASA Supports Small Business Research to Power Future Exploration
26.05.22SILVERCORP REPORTS ADJUSTED EARNINGS OF $52.4 MILLION, $0.30 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $107.4 MILLION FOR FISCAL 2022
26.05.22New Research Demonstrates Genetic Information Can Transform Cancer Care, Guidelines Remain a Barrier to Patient Access
26.05.22Elevation Oncology to Present Initial Seribantumab Proof-of-Concept Data from Phase 2 CRESTONE Study in Patients with Tumors Harboring NRG1 Fusions at ASCO 2022
26.05.22SILVERCORP REPORTS ADJUSTED EARNINGS OF $52.4 MILLION, $0.30 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $107.4 MILLION FOR FISCAL 2022
26.05.22Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2022 ASCO Annual Meeting
26.05.22Electra Makes Steady Progress in Q1 2022 Towards Commissioning its Cobalt Refinery
26.05.22FDA Flexibilities, Collaboration to Yield Millions of Bottles of Specialized Medical Infant Formula in Coming Months to Increase U.S. Supply
26.05.22MILE MARKER INDUSTRIES ANNOUNCES MANAGEMENT CHANGES
26.05.22I-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab
26.05.22Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting CAR-T GC012F for Relapsed/Refractory Multiple Myeloma at 2022 ASCO Annual Meeting
26.05.22Electra Makes Steady Progress in Q1 2022 Towards Commissioning its Cobalt Refinery
26.05.22Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors
26.05.22Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response
26.05.22SQI Diagnostics Reports Second Quarter 2022 Results
26.05.22TriNet to Participate at the Stifel 2022 Cross Sector Insight Conference
26.05.22CTI BioPharma Presents Pivotal Data from Pacritinib Program at the 2022 American Society of Clinical Oncology Annual Meeting
26.05.22Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage Cancers
finanzen.net zero

Aktien kaufen ohne Kosten

finanzen.net zero
Aktien, ETFs, Derivate, Kryptos und mehr jetzt für 0 Euro pro Trade handeln!
JETZT INFORMIEREN
Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
JETZT MEHR ERFAHREN
Zur klassischen Ansicht wechseln
Hilfe & Kontakt
Impressum
Werben
Presse
mehr anzeigen